Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for sleep apnea-associated hypertension crossover trial
2013-004866-33Phase 2Completed
- Sponsor
- University of Gothenburg
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of acetazolamide in obstructive sleep apnea hypopnea syndrome (OSAHS) and hypertension (HTN) (3 arms), sponsored by University of Gothenburg. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 3 more. Started Jan 2014; status: completed.
02
Drugs
acetazolamide
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)hypertension (HTN)
Beyond the preview
Go deeper on 2013-004866-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004866-33.